Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Chemours Company (The) Common Stock (NY: CC )

16.83 -0.96 (-5.40%)
Official Closing Price Updated: 7:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Chemours Company (The) Common Stock

< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
Analyst: As Chemical Sector Takes A Hit, Here Are The 3 Best Stocks To Buy
As the commodity market shifts to an environment of stagflation and U.S. economic recession risks rise, Bank of America adjusted its coverage of chemical stocks on Tuesday. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2022
Upgrades 
Via Benzinga
Analyst Ratings for Chemours
Chemours (NYSE:CC) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Expert Ratings for Chemours
Within the last quarter, Chemours (NYSE:CC) has observed the following analyst ratings: 
Via Benzinga
New Report: Chemours
Chemours' price per share was $32.30 as of Friday's market close. One year ago its price was $29.02. 
Via Talk Markets
Chemours Explores Capacity Investments to Advance Support of the Hydrogen Economy
From The Chemours Company
Via Business Wire
Chemours Announces Process Innovation with New Viton™ Fluoroelastomers Advanced Polymer Architecture (APA) Offering
SOURCE: The Chemours Company 
Via 3BL Media
Topics Supply Chain
Exposures Supply Chain
Chemours Announces Process Innovation with New Viton™ Fluoroelastomers Advanced Polymer Architecture (APA) Offering
From The Chemours Company
Via Business Wire
Chemours Leads Remove2Reclaim Project to Advance Plastic Circularity
From The Chemours Company
Via Business Wire
Chemours Leads Remove2Reclaim Project to Advance Plastic Circularity
SOURCE: The Chemours Company 
Via 3BL Media
Chemours Announces Participation in Versogen’s Development of Clean Hydrogen Technology
From The Chemours Company
Via Business Wire
3 No-Brainer Stocks to Buy for May
Stock investing is not easy but these 3 no-brainer stocks to buy based on their latest earnings have increased their odds of performing well in May. 
Via InvestorPlace
80 Biggest Movers From Yesterday
Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 93.1% to close at $6.45 on Tuesday on above-average volume. XORTX Therapeutics Inc. (NASDAQ: XRTX) gained 59.1% to... 
Via Benzinga
41 Stocks Moving In Tuesday's Mid-Day Session
Gainers SoundHound AI, Inc. (NASDAQ: SOUN) shares jumped 47.4% to $16.13. The company recently completed a SPAC merger deal last week and began trading on Thursday. Sonoma... 
Via Benzinga
Chemours: Q1 Earnings Insights
Chemours (NYSE:CC) reported its Q1 earnings results on Monday, May 2, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Chemours beat estimated earnings by 58.7%,... 
Via Benzinga
The Chemours Company Reports Robust First Quarter 2022 Results
From The Chemours Company
Via Business Wire
Earnings Scheduled For May 2, 2022
Companies Reporting Before The Bell • New Gold (AMEX:NGD) is estimated to report quarterly earnings at $0.03 per share on revenue of $212.42 million. 
Via Benzinga
Chemours and N.C. A&T Partner to Advance Chemistry and Chemical Engineering Education and Opportunities for Students
From Chemours
Via Business Wire
Chemours and N.C. A&T Partner to Advance Chemistry and Chemical Engineering Education and Opportunities for Students
SOURCE: The Chemours Company 
Via 3BL Media
Topics Emissions
Chemours Announces Second Quarter Dividend
From The Chemours Company
Via Business Wire
Overview Of Value Stocks In The Basic Materials Sector
The Meaning Behind Value Stocks A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may... 
Via Benzinga
The Chemours Company (NYSE:CC) Shareholder Notice: Update in Lawsuit
San Diego, CA -- (SBWIRE) -- 04/18/2022 -- An update was announced in the lawsuit that is pending for certain investors in shares of The Chemours Company (NYSE:CC) over alleged Securities Laws... 
Via SBWire
The Chemours Company Announces Date for Thermal & Specialized Solutions Investor Webinar
From The Chemours Company
Via Business Wire
Chemours Announces Dates for First Quarter 2022 Earnings Release and Webcast Conference Call
From The Chemours Company
Via Business Wire
IBD Rating Upgrades: The Chemours Company Flashes Improved Relative Price Strength
The Chemours Company shows rising price performance, earning an upgrade to its IBD Relative Strength Rating 
Via Investor's Business Daily
Chemours, National Hockey League, and Snider Hockey Partner to Bring a Robust STEM Program to Students at Drexel Neumann Academy
SOURCE: The Chemours Company 
Via 3BL Media
Chemours, National Hockey League, and Snider Hockey Partner to Bring a Robust STEM Program to Students at Drexel Neumann Academy
From The Chemours Company
Via Business Wire
The Chemours Company (NYSE:CC) Shareholder Notice: Update in Lawsuit
San Diego, CA -- (SBWIRE) -- 03/14/2022 -- The Shareholders Foundation announced an update in the lawsuit that is pending for certain investors in shares of The Chemours Company (NYSE:CC). 
Via SBWire
Chemours Achieves Great Place to Work® Certification in Switzerland
SOURCE: The Chemours Company 
Via 3BL Media
78 Biggest Movers From Friday
Gainers Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) surged 26% to close at $2.24. Y-mAbs reported completion of pre-BLA meeting with the FDA for Omburtamab. China Online Education... 
Via Benzinga
< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.